Nicholas G. Nickols, Ph.D.
Affiliations: | 2008 | Chemistry | California Institute of Technology, Pasadena, CA |
Area:
DNA recognitionGoogle:
"Nicholas Nickols"Mean distance: 7.52 | S | N | B | C | P |
Parents
Sign in to add mentor| Peter B. Dervan | grad student | 2008 | Caltech | |
| (Endogenous Gene Regulation by DNA Binding Polyamides.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Levin-Epstein R, Cook RR, Wong JK, et al. (2020) Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3,502 patients. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology |
| Parikh NR, Kishan AU, Kane N, et al. (2020) Phase I Trial of Stereotactic Body Radiotherapy Neoadjuvant to Radical Prostatectomy for Patients with High-Risk Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics |
| Dang AT, Levin-Epstein RG, Shabsovich D, et al. (2020) Gantry-Mounted Linear Accelerator-Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer. Advances in Radiation Oncology. 5: 404-411 |
| Valle LF, Ruan D, Dang A, et al. (2020) Development and Validation of a Comprehensive Multivariate Dosimetric Model for Predicting Late Genitourinary Toxicity Following Prostate Cancer Stereotactic Body Radiotherapy. Frontiers in Oncology. 10: 786 |
| Kishan AU, Romero T, Alshalalfa M, et al. (2020) Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate Cancer. European Urology |
| Levin-Epstein R, Qiao-Guan G, Juarez JE, et al. (2020) Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate Cancer. Frontiers in Oncology. 10: 539 |
| Nickols NG, Ganapathy E, Nguyen C, et al. (2020) The intraprostatic immune balance after prostate SBRT in patients. Journal of Clinical Oncology. 38: 339-339 |
| Parikh NR, Chang EM, Nickols NG, et al. (2020) Cost-effectiveness of upfront therapeutic options in low-volume de novo metastatic hormone-sensitive prostate cancer. Journal of Clinical Oncology. 38: 211-211 |
| Dadashian E, Nakazawa M, Parikh NR, et al. (2020) Clinically relevant genomic alterations identified by targeted exome sequencing in U.S. veterans with prostate cancer. Journal of Clinical Oncology. 38: e17599-e17599 |
| Armstrong WR, Thin P, Nguyen K, et al. (2020) Comparison of recurrence patterns after surgery and radiation therapy with 68Ga-PSMA-11 PET/CT in nonmetastatic castrate-sensitive prostate cancer patients: A single-center post-hoc retrospective analysis in 787 patients. Journal of Clinical Oncology. 38: 3577-3577 |